Analysts upgraded Rocket Pharma, Generac, Palantir, Global Payments and Unity Software, with new or

Goldman Sachs analyst Richard Law upgrades Rocket Pharmaceuticals (NASDAQ:RCKT) from Sell to Neut

Leerink Partners analyst Roanna Ruiz maintains Rocket Pharmaceuticals (NASDAQ:RCKT) with a Market

Rocket Pharmaceuticals (NASDAQ: RCKT) shares rose 4% on Wednesday after the biotechnology company se

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated commercial-stage biotechnology compa

CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated com

Wedbush analyst Yun Zhong reiterates Rocket Pharmaceuticals (NASDAQ:RCKT) with a Outperform and m

Rocket Pharmaceuticals (NASDAQ: RCKT - Get Free Report)'s stock had its "buy" rating reissued by Cha

Rocket Pharmaceuticals (NASDAQ: RCKT) outlined updated clinical, regulatory and commercial plans for

Rocket Pharmaceuticals, Inc. (RCKT) Discusses Danon Disease Program Update With Focus on RP-A501 Piv

Rocket Pharmaceuticals NASDAQ: RCKT outlined updated clinical, regulatory and commercial plans for i

CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, co

Analysts upgraded SUNB, HAWK, and more, revising ratings and price targets.

Rocket Pharmaceuticals aligns with the FDA on key phase II study elements for RP-A501, advancing its

Analysts upgraded Similarweb, Rocket Pharmaceuticals, Radiant Logistics and Ulta Beauty; Paychex ros

Wedbush analyst Yun Zhong reiterates Rocket Pharmaceuticals (NASDAQ:RCKT) with a Outperform and m

As the Federal Reserve prepares to move on rates and oil prices surge past $105, Wednesday's top ana

Needham analyst Gil Blum upgrades Rocket Pharmaceuticals (NASDAQ:RCKT) from Hold to Buy and annou

Rocket Pharmaceuticals, Inc. (RCKT) Presents at Morgan Stanley 24th Annual Global Healthcare Confere

Rocket Pharmaceuticals, Inc. (RCKT) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conf

[url="]Rocket Pharmaceuticals, Inc.[/url] (NASDAQ: RCKT), a fully integrated, commercial-stage biote

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT), a fully integrated, commercial-stage biotechnology compa

CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, co

Rocket Pharmaceuticals (RCKT) reported earnings 30 days ago. What's next for the stock?

CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, co

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT - Get Free Report) has received a consensus rating of "Ho

RCKT records earnings growth in the second quarter. Kresladi launch preparations advance and RP-A501

Wedbush analyst Yun Zhong maintains Rocket Pharmaceuticals (NASDAQ:RCKT) with a Outperform and lo

Rocket Pharmaceuticals (NASDAQ:RCKT) reported quarterly losses of $(0.37) per share which missed the

CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, co

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) on Monday shared a clinical safety update concerning the

Rocket Pharmaceuticals announces positive early safety results for its RP-A501 Phase 2 trial in Dano

[url="]Rocket Pharmaceuticals, Inc.[/url] (Rocket or the Company) (NASDAQ: RCKT), a fully integrated

Initial three patients were treated safely; RP-A501 was well-tolerated with no TMA or capillary leak

Gainers American Shared Hospital (AMEX:AMS) stock rose 14.2% to $1.61 during Wednesday's after-

The Rare Pediatric Disease Priority Review Voucher was granted by the FDA in March 2026 in connectio

Rocket Pharmaceuticals (NASDAQ:RCKT) reported quarterly losses of $(0.42) per share which beat the a

Top analysts changed ratings for OVV, ALMS, CLMT, LGN, RCKT, UTHR, VNT, HOOD. See full changes at be

William Blair notes FDA's tougher stance on gene therapy programs as AMT-130 faces uncertainty i

Vinay Prasad exits FDA's biologics division following pressure over Sarepta's Elevidys appro

Benzinga examined the prospects for many investors' favorite stocks over the last week — here&#3